Considerations in the use of COX-2 inhibitors in spinal fusion surgery

Anesth Analg. 2001 Sep;93(3):803-4. doi: 10.1097/00000539-200109000-00056.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / adverse effects
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Humans
  • Isoenzymes / metabolism*
  • Membrane Proteins
  • Osteogenesis / drug effects
  • Pain, Postoperative / drug therapy*
  • Prostaglandin-Endoperoxide Synthases / metabolism*
  • Spinal Fusion*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Membrane Proteins
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases